Past the pill and product: What do VCs want?
During a panel at MedCity INVEST, four experts addressed what VCs and potential acquirers are looking for in emerging companies.
During a panel at MedCity INVEST, four experts addressed what VCs and potential acquirers are looking for in emerging companies.
In an outcomes-driven environment, focusing on patients is key but value needs to be demonstrated for all stakeholders when adopting new strategies to go beyond the pill.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Amgen is looking for a senior counsel as part of an expansion of its digital health team. Guess who they contacted?
Neuromodulation is being eyed as one of the beyond-the-pill growth fields of the future. Here are five ways startups are using this technology.